da Costa Francisco Diniz Affonso, Etnel Jonathan R G, Torres Renato, Balbi Filho Eduardo M, Torres Rafael, Calixto Allyson, Mulinari Leonardo A
1 Department of Cardiac Surgery, Santa Casa de Curitiba-PUCPR and Hospital Infantil Pequeno Príncipe, Curitiba, Brazil.
2 Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
World J Pediatr Congenit Heart Surg. 2017 Sep;8(5):605-612. doi: 10.1177/2150135117723916.
Determine the midterm outcomes of decellularized allografts for right ventricular outflow tract (RVOT) reconstruction in children less than 12 years of age.
The study included all consecutive patients submitted to RVOT reconstruction with decellularized allografts between June 2006 and June 2016. Besides clinical and echocardiographic control, 20 patients with more than five years of follow-up were evaluated with computed tomography (CT) scans to determine allograft diameters and calcium scores. Structural valve deterioration was defined as any peak gradient above 40 mm Hg and/or insufficiency of moderate or severe degree. Conduit failure was defined as the need for allograft reintervention.
There were 59 patients with a median age of six years (range = 0.01-12 years). The most common operation was the Ross procedure (34%). Mean clinical follow-up was 5.4 (2.8) years and was 94% complete. At eight years, only two patients needed a reintervention, with a 90.9% freedom from this event. Structural valve deterioration occurred in 13 patients, 5 due to stenosis and 8 due to insufficiency, with a freedom from structural valve deterioration due to any cause of 64.9% at eight years. Late CT scans demonstrated the absence or minimal calcification of the conduits.
Decellularized allografts for RVOT reconstruction in children were associated with a low incidence of structural valve deterioration and conduit failure. Although these results still need to be confirmed in larger series and with longer follow-up, our data suggest favorable outcomes, at least in the first decade after the operation.
确定用于12岁以下儿童右心室流出道(RVOT)重建的去细胞同种异体移植物的中期结果。
该研究纳入了2006年6月至2016年6月期间所有接受去细胞同种异体移植物进行RVOT重建的连续患者。除了临床和超声心动图检查外,对20例随访超过5年的患者进行了计算机断层扫描(CT),以确定同种异体移植物的直径和钙化评分。结构瓣膜恶化定义为任何峰值梯度高于40 mmHg和/或中度或重度反流。管道衰竭定义为需要对同种异体移植物进行再次干预。
共有59例患者,中位年龄为6岁(范围=0.01-12岁)。最常见的手术是Ross手术(34%)。平均临床随访时间为5.4(2.8)年,随访完成率为94%。8年时,只有2例患者需要再次干预,无再次干预事件的发生率为90.9%。13例患者发生了结构瓣膜恶化,5例因狭窄,8例因反流,8年时因任何原因导致的结构瓣膜恶化的无发生率为64.9%。晚期CT扫描显示管道无钙化或钙化极少。
用于儿童RVOT重建的去细胞同种异体移植物与结构瓣膜恶化和管道衰竭的低发生率相关。尽管这些结果仍需要在更大规模的系列研究和更长时间的随访中得到证实,但我们的数据表明至少在术后的第一个十年结果良好。